China FDA Transparency Guidance

[membership level=”0,4″][The content continues for paid members only.] Login or Subscribe
[/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership] In order to improve the transparency of drug approvals, the China FDA issued draft guidance outlining the content and basic requirements of information disclosures to the public.
[/membership]